Japan's Drug Approval Data. Finally in English.
Search, analyze, and monitor PMDA review reports — structured, translated, and updated daily.
PMDA publishes 500+ drug approvals per year. Only ~300 have ever been translated to English.
The Problem
The world's 3rd largest pharmaceutical market is locked behind a language barrier
Japanese-Only PDFs
Critical review reports, approval documents, and regulatory data are published exclusively in Japanese as unstructured PDF files.
No Structured Data or API
No machine-readable format, no search API, no structured database. Teams spend hours manually extracting data from scattered documents.
Weeks of Waiting
Hiring consultants or translation firms means weeks of turnaround time and thousands of dollars for a single review report.
The Solution
PMDA data, structured and translated
PharmaLens transforms raw Japanese regulatory documents into an actionable English intelligence platform.
Structured English Database
Every approval translated and organized into searchable, structured records.
Daily Monitoring & Alerts
Get notified the moment new approvals or safety updates are published.
Search by Drug / Indication / Company
Find exactly what you need with powerful filters across all PMDA data.
Full Review Report Summaries
AI-generated English summaries of complete PMDA review reports.
Recent Drug Approvals
| Drug Name | Company | Indication | Date | Status |
|---|---|---|---|---|
| Keytruda | MSD K.K. | Non-small cell lung cancer | 2026-03-15 | Translated |
| Enhertu | Daiichi Sankyo | HER2+ breast cancer | 2026-03-12 | Translated |
| Opdivo | Ono Pharmaceutical | Gastric cancer | 2026-03-08 | In Progress |
| Leqembi | Eisai | Alzheimer's disease | 2026-02-28 | Translated |
Pricing
Simple, transparent pricing
Choose the plan that fits your regulatory intelligence needs.
Starter
For individuals exploring the Japanese pharma market.
- Search & browse drug database
- 20 full reports per month
- Basic search filters
- Email support
Professional
For regulatory affairs teams that need comprehensive access.
- Unlimited report access
- Daily monitoring & alerts
- Full API access
- Advanced search & filters
- Export to CSV / PDF
- Priority email support
Enterprise
For organizations requiring full historical coverage.
- Everything in Professional
- Team accounts (up to 10 seats)
- Full historical data (18+ years)
- Custom integrations
- Dedicated account manager
- Priority support & SLA
Get Early Access
Be the first to know when we launch. Early subscribers get 30% off their first year.
No spam. Unsubscribe anytime. We'll only email you about PharmaLens.